ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $874 | -78.2% | 36,483 | +11160.2% | 0.46% | +4090.9% |
| Q2 2022 | $4,000 | -89.5% | 324 | -79.5% | 0.01% | -67.6% |
| Q1 2022 | $38,000 | -50.0% | 1,584 | -51.5% | 0.03% | -68.8% |
| Q4 2021 | $76,000 | +1166.7% | 3,266 | +1196.0% | 0.11% | +1716.7% |
| Q2 2021 | $6,000 | -96.3% | 252 | -96.0% | 0.01% | -96.6% |
| Q1 2021 | $161,000 | -29.7% | 6,258 | +46.2% | 0.18% | -31.0% |
| Q4 2020 | $229,000 | +74.8% | 4,279 | +34.0% | 0.26% | +91.7% |
| Q3 2020 | $131,000 | -70.9% | 3,193 | -81.0% | 0.13% | -21.8% |
| Q2 2020 | $450,000 | +60.1% | 16,832 | +152.7% | 0.17% | -62.9% |
| Q1 2020 | $281,000 | -37.6% | 6,661 | -60.4% | 0.46% | +80.3% |
| Q2 2019 | $450,000 | +592.3% | 16,832 | +589.6% | 0.25% | +586.5% |
| Q1 2019 | $65,000 | – | 2,441 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |